(RTTNews) - Cipla USA Inc. the wholly owned subsidiary of Cipla Limited (500087, CIPLA) announced that it has received final approval from U.S. FDA for Abbreviated New Drug Application or ANDA for Nintedanib Capsules, 100 mg and 150 mg, for the treatment of Idiopathic Pulmonary
Loading story…

